Tuesday, 15 September 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - India-news https://ift.tt/2Rxkbqa
at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Assam May Gain 63 New Assembly Seats Under Women's Quota: Himanta Sarma

Chief Minister Himanta Biswa Sarma announced on Saturday that the state's total assembly seats could rise from 126 to 189, a net gain of...